Request Free Sample ×
Coronary Artery Bypass Graft Market Research Report- Global Forecast to 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Coronary Artery Bypass Graft Market

ID: MRFR/MED/1678-HCR
80 Pages
Satyendra Maurya
March 2026

Coronary Artery Bypass Graft Market Research Report Information By Type (Off-Pump, On-Pump, Minimally Invasive Direct CABG, Endoscopic Vein Harvesting and Others), By Procedure (Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, Quadruple CABG Surgery and Others), By End-User (Hospitals, Cardiology Clinics, Research Institutes and Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Coronary Artery Bypass Graft Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Methodology Download PDF

Coronary Artery Bypass Graft Market Summary

As per Market Research Future Reports analysis, the Coronary Artery Bypass Graft Market size was valued at USD 13.31 Billion in 2024. The market is projected to grow from USD 14.4 Billion in 2025 to USD 31.73 Billion by 2035, exhibiting a CAGR of 8.22% during the forecast period 2025–2035. North America led the market with over 50% share, generating around USD 6.66 billion in revenue.
 
The market is driven by rising prevalence of coronary artery disease, aging populations, and technological advancements in minimally invasive and robotic-assisted surgeries enhancing precision, reducing recovery times, and improving patient outcomes.
 
WHO reports cardiovascular diseases cause 17.9 million deaths annually, with CAD being the leading cause, highlighting rising demand for surgical interventions.

Key Market Trends & Highlights

The Coronary Artery Bypass Graft Market is experiencing a dynamic shift driven by technological advancements and increasing health awareness.

  • North America leads, accounting for over 50% of global CABG revenue in 2024.
  • Traditional CABG dominates with 70% share; Robotic-Assisted grows fastest at 30% share.
  • Coronary Artery Disease largest application at 63%; Myocardial Ischemia fastest-growing at 37%.
  • In-Hospital Care largest post-surgery segment at 75%; Rehabilitation Programs expanding rapidly at 25%.

Market Size & Forecast

2024 Market Size 13.31 (USD Billion)
2035 Market Size 31.73 (USD Billion)
CAGR (2025 - 2035) 8.22%

Major Players

Companies such as Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Stryker Corporation (US), Edwards Lifesciences Corporation (US), Cardinal Health (US) are some of the major participants in the global market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Coronary Artery Bypass Graft Market Trends

The Coronary Artery Bypass Graft Market is currently experiencing notable transformations driven by advancements in surgical techniques and technologies. Innovations in minimally invasive procedures are reshaping the landscape, allowing for reduced recovery times and improved patient outcomes. Furthermore, the integration of robotic-assisted surgeries appears to enhance precision, which may lead to a growing preference among healthcare providers for these advanced methods.

As the demand for effective cardiovascular treatments continues to rise, the market is likely to witness an influx of new products and solutions aimed at addressing various patient needs. In addition to technological advancements, the market is influenced by an increasing awareness of heart health and preventive measures.

Educational initiatives and public health campaigns seem to play a crucial role in promoting early diagnosis and intervention, which could potentially lead to a higher volume of surgical procedures. Moreover, the aging population is expected to contribute to the market's expansion, as older individuals are more susceptible to coronary artery diseases. Overall, the market is poised for growth, driven by a combination of innovation, awareness, and demographic shifts.

Technological Advancements

The Coronary Artery Bypass Graft Market is witnessing a surge in technological innovations, particularly in surgical techniques. The emergence of minimally invasive procedures and robotic-assisted surgeries is transforming traditional practices, enhancing precision and reducing recovery times for patients.

obotic-assisted and minimally invasive CABG surgeries improve precision and reduce complications. IHME data shows surgical mortality for cardiac procedures decreased by 22% from 2010 to 2020 due to advanced techniques

Increased Awareness of Heart Health

Growing public awareness regarding cardiovascular health is influencing the Coronary Artery Bypass Graft Market. Educational campaigns and initiatives aimed at promoting heart health are likely to lead to earlier diagnoses and increased surgical interventions.

Public education promotes early diagnosis and intervention. CDC indicates awareness campaigns increased heart disease screenings by 18% between 2015–2022, leading to timely interventions and better outcomes

Aging Population

The demographic shift towards an older population is expected to impact the market significantly. As the prevalence of coronary artery diseases rises among older adults, the demand for surgical interventions is anticipated to increase.

Older adults (65+) are more susceptible to CAD, driving CABG demand. UNFPA projects global population aged 65+ will reach 1.5 billion by 2050, emphasizing the growing need for cardiovascular surgical care UNFPA

Coronary Artery Bypass Graft Market Drivers

Market Growth Projections

The Global Coronary Artery Bypass Graft Market is projected to experience substantial growth over the next decade. By 2024, the market is expected to reach 13.3 USD Billion, with further expansion anticipated to 31.7 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate of 8.22% from 2025 to 2035.
 
Such projections reflect the increasing demand for coronary artery bypass grafting procedures, driven by factors such as the aging population, rising prevalence of cardiovascular diseases, and advancements in surgical technologies. The market's robust growth is indicative of the critical role that coronary artery bypass grafting plays in modern cardiovascular care.

Growing Geriatric Population

The increasing geriatric population worldwide is a crucial factor driving the Global Coronary Artery Bypass Graft Market Industry. Older adults are more susceptible to cardiovascular diseases due to age-related physiological changes and the accumulation of risk factors over time.
 
As the global population ages, the demand for coronary artery bypass grafting is anticipated to rise significantly. This demographic shift necessitates healthcare systems to adapt and expand their cardiovascular care services. The market is expected to grow at a compound annual growth rate of 8.22% from 2025 to 2035, reflecting the urgent need for surgical interventions among the aging population.

Rising Healthcare Expenditure

An increase in healthcare expenditure across various regions is propelling the Global Coronary Artery Bypass Graft Market Industry. Governments and private sectors are investing more in healthcare infrastructure, which includes advanced surgical facilities and technologies. This trend is particularly evident in developing countries, where improving healthcare access and quality is a priority.
 
As healthcare budgets expand, more patients gain access to necessary surgical procedures, including coronary artery bypass grafting. This growing investment is likely to enhance the market's growth trajectory, supporting the projected increase in market value to 31.7 USD Billion by 2035.

Awareness and Education Initiatives

Awareness and education initiatives regarding cardiovascular health are playing a pivotal role in the Global Coronary Artery Bypass Graft Market Industry. Public health campaigns aimed at educating individuals about the risks of cardiovascular diseases and the benefits of early intervention are becoming increasingly prevalent.
 
These initiatives encourage individuals to seek medical advice and treatment sooner, leading to higher rates of diagnosis and subsequent surgical interventions. As awareness grows, so does the demand for coronary artery bypass grafting, thereby driving market growth. The emphasis on preventive care and education is expected to sustain the market's expansion in the coming years.

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases globally is a primary driver for the Global Coronary Artery Bypass Graft Market Industry. According to health statistics, cardiovascular diseases remain the leading cause of mortality worldwide, accounting for approximately 31% of all deaths. This alarming trend necessitates effective surgical interventions, such as coronary artery bypass grafting, to restore blood flow and improve patient outcomes.
 
As the population ages and lifestyle-related risk factors proliferate, the demand for bypass surgeries is expected to surge, contributing to the market's growth. The Global market is projected to reach 13.3 USD Billion by 2024, reflecting this urgent healthcare need.

Technological Advancements in Surgical Techniques

Innovations in surgical techniques and technologies are significantly influencing the Global Coronary Artery Bypass Graft Market Industry. The advent of minimally invasive procedures, robotic-assisted surgeries, and advanced imaging technologies has enhanced the precision and safety of bypass grafting. These advancements not only reduce recovery times but also improve surgical outcomes, making the procedure more appealing to both patients and healthcare providers.
 
 As hospitals adopt these cutting-edge technologies, the market is likely to experience accelerated growth. The integration of such innovations is expected to contribute to the projected market value of 31.7 USD Billion by 2035, indicating a robust future for the Global market.

Market Segment Insights

By Application: Coronary Artery Disease (Largest) vs. Myocardial Ischemia (Fastest-Growing)

In the Coronary Artery Bypass Graft Market, the application segment shows a clear distribution, with various cardiovascular conditions collectively accounting for a significant 63% market share. Coronary Artery Disease (CAD) holds the largest portion, driven by its prevalence and the high rates of associated surgical interventions. This condition significantly shapes the demand for bypass grafts. Following CAD, Myocardial Ischemia emerges as a rapidly growing application, reflecting increasing awareness and diagnosis rates that fuel market growth. Conversely, Heart Valve Disease, Aneurysm, and other cardiovascular conditions contribute to the market but do so at a slower pace due to relative complexities and lower prevalence rates.

Coronary Artery Disease (Dominant) vs. Myocardial Ischemia (Emerging)

Coronary Artery Disease remains the dominant application within the market share. This condition is characterized by obstructed blood flow, resulting in significant morbidity and mortality risks. As diagnostic capabilities improve and lifestyle changes increase risk factors, the need for effective surgical interventions remains high. On the other hand, Myocardial Ischemia is emerging as a vital segment, marked by angina and the potential for acute myocardial infarction. It benefits from technological advancements in imaging and treatment approaches, generating a rising demand for graft procedures as more patients are identified and treated.

By Surgical Technique: Traditional CABG (Largest) vs. Robotic-Assisted CABG (Fastest-Growing)

In the Coronary Artery Bypass Graft (CABG) Market, Traditional Coronary Artery Bypass Grafting dominates the surgical techniques segment, accounting for a significant 70% market share. This method has been a cornerstone in cardiac surgery for decades, leveraging standard surgical methods to address coronary artery disease. In contrast, Minimally Invasive CABG and Off-Pump CABG are progressively gaining traction, holding a notable share of the market, while Robotic-Assisted CABG exhibits the most rapid growth driven by technological advancements and an increasing preference for less invasive procedures. As healthcare systems innovate, there is a pronounced shift towards techniques that minimize patient recovery time and surgical risks. The allure of Minimally Invasive CABG and Robotic-Assisted CABG is driven by their ability to reduce trauma and improve outcomes for patients, encouraging surgical practitioners to adopt these cutting-edge methods. Moreover, growing patient awareness and demand for personalized and less invasive surgical options further propel the expansion of these advanced techniques. As the market evolves, Traditional CABG remains fundamental, yet the rising popularity of novel techniques marks a significant trend in the coronary artery bypass graft procedure landscape.

Traditional CABG (Dominant) vs. Robotic-Assisted CABG (Emerging)

Traditional Coronary Artery Bypass Grafting (CABG) remains the dominant technique within the surgical segment, celebrated for its reliability and established efficacy in treating advanced coronary artery disease. This method typically involves a median sternotomy and the use of the patient's arteries or veins to bypass obstructed coronary vessels. In contrast, Robotic-Assisted CABG is emerging as a pioneering alternative, leveraging robotic systems to perform minimally invasive surgery with heightened precision. This technique aims to offer patients reduced postoperative pain and quicker recovery times, appealing to the growing demographic seeking advanced treatment options. While Traditional CABG holds strong in the market, the innovative approach of Robotic-Assisted CABG is capturing interest, positioning it as a formidable contender for future growth in the surgical landscape.

By Type of Graft: Saphenous Vein Graft (Largest) vs. Internal Mammary Artery Graft (Fastest-Growing)

In the Coronary Artery Bypass Graft Market, the Saphenous Vein Graft (SVG) holds the leading position, capturing a 65% share due to its widespread use and proven effectiveness in surgical procedures. Meanwhile, the Internal Mammary Artery Graft (IMAG) has been gaining traction and is recognized as a rapidly growing segment, primarily due to advancements in surgical techniques and an increase in minimally invasive procedures. The demand for grafts in coronary artery bypass surgeries highlights the essential role these graft types play. The growth trends for these graft types are driven by several factors, including an aging population, rising rates of coronary artery disease, and improvements in surgical methodologies. Additionally, the awareness of the benefits specific to each graft type affects their adoption rates, with IMAG showing promise as patients and physicians alike recognize its benefits over traditional graft options. Overall, the growth of the Internal Mammary Artery Graft segment indicates a shift towards more specialized and effective treatments within the market.

Saphenous Vein Graft (Dominant) vs. Radial Artery Graft (Emerging)

The Saphenous Vein Graft (SVG) continues to dominate the market share due to its robustness and long-standing history of successful outcomes. SVG is commonly selected for its ease of harvesting and flexibility in usage, representing a trusted option among surgeons. Conversely, the Radial Artery Graft (RAG) is emerging as a potential alternative, favored for its long-term patency rates and lower risk of complications associated with harvesting. As surgical techniques improve and the medical community becomes more aware of the benefits associated with RAG, this graft type is poised to experience increased adoption. The shift from SVG to RAG could signify a broader trend toward utilizing the most effective grafts in coronary artery bypass procedures, reflecting an overall movement towards enhanced patient outcomes.

By Patient Demographics: Age Group (Largest) vs. Comorbidities (Fastest-Growing)

In the Coronary Artery Bypass Graft Market, the demographic distribution indicates that older adults, especially those aged 65 and above, account for the largest segment with a 68% share. This age group is greatly affected by cardiovascular diseases, leading to a higher demand for CABG procedures. On the other hand, the prevalence of patients with multiple comorbidities, such as diabetes and hypertension, is witnessing substantial growth. This shift indicates a rising patient population requiring complex interventions, reflecting broader healthcare trends where chronic diseases are on the rise across various age groups.

Age Group: 65+ (Dominant) vs. Comorbidities (Emerging)

The patient demographics for the market reveal a dominant presence of individuals aged 65 and above, primarily due to aging populations globally. This cohort typically exhibits higher risks for coronary artery diseases, making CABG a frequently chosen treatment option. In contrast, the emerging concern regarding patients with comorbidities signifies a changing landscape in cardiac care. These patients often present with unique challenges requiring tailored surgical approaches, thus driving innovation in surgical techniques and postoperative care. The intersection of these demographic factors emphasizes the need for healthcare providers to adapt strategies and improve outcomes for these distinct yet intertwined patient populations.

By Postoperative Care: In-Hospital Care (Largest) vs. Rehabilitation Programs (Fastest-Growing)

In the Coronary Artery Bypass Graft Market, the postoperative care segment includes in-hospital care, home care, rehabilitation programs, and long-term follow-up, with in-hospital care leading the segment by holding a dominant 75% market share due to its critical role in immediate post-surgical recovery. Patients generally require intensive monitoring and medical intervention in hospital settings, which solidifies its significance. In contrast, Rehabilitation Programs have emerged as the fastest-growing segment in response to the increasing recognition of structured recovery protocols. As healthcare systems prioritize holistic patient care, these programs are expanding rapidly.

Rehabilitation Programs (Emerging) vs. Long-Term Follow-Up (Dominant)

Rehabilitation Programs are gaining traction as an essential part of postoperative care for patients who have undergone coronary artery bypass graft surgery. These programs are designed to facilitate recovery through supervised exercise, education, and support, addressing both physical and emotional healing. Their emergence is driven by a trend toward preventive care and improved patient outcomes, often resulting in reduced hospital readmissions. Conversely, Long-Term Follow-Up remains a dominant component in this market, providing ongoing monitoring and support to ensure the patient's health over time. These follow-up services are crucial for maintaining heart health and managing risk factors, making them indispensable for both patients and healthcare providers.

Get more detailed insights about Coronary Artery Bypass Graft Market
Request Free Sample

Regional Insights

North America : Market Leader in Innovation

North America leads in the Coronary Artery Bypass Graft Market, accounting for over 50% of the global revenue in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on innovative surgical techniques. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring the availability of cutting-edge medical devices and technologies.

The competitive landscape in North America is robust, featuring key players such as Medtronic, Boston Scientific, and Abbott Laboratories. These companies are at the forefront of technological advancements, contributing to improved patient outcomes. The U.S. remains the largest market, supported by high healthcare expenditure and a growing aging population. This dynamic environment fosters continuous innovation and strategic partnerships among leading firms, solidifying North America's position in the global market.

Europe : Emerging Market with Growth Potential

Europe's Coronary Artery Bypass Graft market is projected to grow, with a market size of 3.99 in 2024. The region benefits from a well-established healthcare system, increasing awareness of cardiovascular health, and supportive regulatory frameworks. Initiatives by the European Medicines Agency (EMA) to streamline approvals for innovative therapies are expected to enhance market dynamics, driving demand for advanced surgical solutions.

Leading countries in Europe include Germany, France, and the UK, where significant investments in healthcare technology are evident. The competitive landscape features prominent players like B. Braun Melsungen AG and Terumo Corporation, who are actively involved in research and development. The presence of these key players, along with a growing emphasis on minimally invasive procedures, positions Europe as a vital market for coronary artery bypass grafts.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific region is experiencing significant growth in the Coronary Artery Bypass Graft market, with a market size of 2.22 in 2024. Factors such as rising disposable incomes, increasing prevalence of heart diseases, and improvements in healthcare infrastructure are driving demand. Additionally, government initiatives aimed at enhancing healthcare access and affordability are expected to further stimulate market growth in this region.

Countries like Japan, China, and India are leading the charge, with a growing number of hospitals adopting advanced surgical techniques. The competitive landscape is characterized by the presence of key players such as Stryker Corporation and Edwards Lifesciences. These companies are focusing on expanding their product offerings and enhancing service delivery to meet the rising demand for coronary artery bypass grafts in the region.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region presents untapped opportunities in the Coronary Artery Bypass Graft market, with a market size of 0.44 in 2024. The growth is driven by increasing healthcare investments, rising awareness of cardiovascular diseases, and a growing population. Governments are prioritizing healthcare reforms, which are expected to enhance access to surgical procedures and improve patient outcomes across the region.

Leading countries such as South Africa and the UAE are making strides in healthcare infrastructure, attracting investments from global players. The competitive landscape is evolving, with companies like Cardinal Health expanding their presence. As the region continues to develop, the demand for advanced surgical solutions is anticipated to rise, creating a favorable environment for market growth.

Coronary Artery Bypass Graft Market Regional Image

Key Players and Competitive Insights

The Coronary Artery Bypass Graft Market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansions. Key players such as Medtronic (US), Boston Scientific (US), and Abbott Laboratories (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on technological advancements in graft materials, while Boston Scientific (US) emphasizes the integration of digital health solutions into their offerings.
 
Abbott Laboratories (US) appears to be leveraging strategic acquisitions to bolster its product portfolio, thereby enhancing its competitive edge. Collectively, these strategies contribute to a dynamic environment where innovation and adaptability are paramount. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency.
 
This approach is particularly relevant in a moderately fragmented market where the influence of key players is significant. The competitive structure is evolving, with larger firms seeking to consolidate their positions through mergers and acquisitions, while smaller entities focus on niche innovations. This duality creates a complex market landscape where agility and responsiveness are critical. In November 2025, Medtronic (US) announced a partnership with a leading AI firm to develop predictive analytics tools aimed at improving patient outcomes in cardiac surgeries.
 
This strategic move underscores Medtronic's commitment to integrating advanced technologies into its product offerings, potentially setting a new standard for patient care in the bypass graft sector. The collaboration is likely to enhance Medtronic's competitive positioning by aligning its products with the growing demand for data-driven healthcare solutions. In October 2025, Boston Scientific (US) launched a new line of bioresorbable stents designed specifically for use in bypass graft procedures.
 
This innovation not only reflects the company's focus on sustainability but also addresses the increasing demand for less invasive surgical options. By introducing such products, Boston Scientific (US) may strengthen its market share and appeal to a broader range of healthcare providers seeking advanced solutions. In September 2025, Abbott Laboratories (US) completed the acquisition of a smaller biotech firm specializing in graft technology.
 
This acquisition is indicative of Abbott's strategy to enhance its technological capabilities and expand its product offerings in the coronary artery bypass graft market. The integration of this new technology could provide Abbott with a competitive advantage, allowing it to offer more comprehensive solutions to healthcare providers. As of December 2025, the competitive trends in the market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence.
 
 Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, the competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains. This shift suggests that companies that prioritize R&D and strategic partnerships will be better positioned to thrive in an increasingly complex market.

Key Companies in the Coronary Artery Bypass Graft Market include

Industry Developments

August 2022: Grand Pharmaceutical Company, a Chinese pharmaceutical company, has made a 15 million euro investment in Xeltis, a renowned manufacturer of medical equipment with its Dutch headquarters. Grand Pharmaceutical has developed a polymer-based cardiovascular restorative device. One of the restoration devices used in coronary artery bypass graft (CABG) surgery is a heart valve. Another is a blood vessel with a small diameter.

January 2022: Results from the first preclinical trial using Humacyte's small-diameter (3.5mm) Human Acellular Vessel (HAV) in coronary artery bypass grafting (CABG) have been released by the company. These results were presented at Advanced Therapies Week.

Future Outlook

Coronary Artery Bypass Graft Market Future Outlook

The Coronary Artery Bypass Graft Market size is projected to reach USD 31.73 Billion by 2035, growing at a CAGR of 8.22%, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising healthcare expenditure.

New opportunities lie in:

  • Development of minimally invasive surgical techniques to enhance patient recovery. Expansion of telehealth services for pre- and post-operative care. Investment in advanced biomaterials for grafts to improve long-term outcomes.

By 2035, the market is expected to achieve substantial growth, reflecting advancements and increased demand.

Market Segmentation

Coronary Artery Bypass Graft Market Application Outlook

  • Coronary Artery Disease
  • Myocardial Ischemia
  • Heart Valve Disease
  • Aneurysm
  • Other Cardiovascular Conditions

Coronary Artery Bypass Graft Market Type of Graft Outlook

  • Saphenous Vein Graft
  • Internal Mammary Artery Graft
  • Radial Artery Graft
  • Composite Graft

Coronary Artery Bypass Graft Market Surgical Technique Outlook

  • Traditional Coronary Artery Bypass Grafting
  • Minimally Invasive Coronary Artery Bypass Grafting
  • Off-Pump Coronary Artery Bypass Grafting
  • Robotic-Assisted Coronary Artery Bypass Grafting

Report Scope

MARKET SIZE 2024 13.31(USD Billion)
MARKET SIZE 2025 14.4(USD Billion)
MARKET SIZE 2035 31.73(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 8.22% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Stryker Corporation (US), Edwards Lifesciences Corporation (US), Cardinal Health (US)
Segments Covered Application, Surgical Technique, Type of Graft
Key Market Opportunities Integration of advanced minimally invasive techniques in the market.
Key Market Dynamics Technological advancements and regulatory changes are reshaping the competitive landscape of the market.
Countries Covered North America, Europe, APAC, South America, MEA

Market Highlights

Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

FAQs

What is the projected market valuation of the Coronary Artery Bypass Graft Market by 2035?

The projected market valuation for the market is 31.73 USD Billion by 2035.

What was the market valuation of the market in 2024?

The market valuation of the market  was 13.31 USD Billion in 2024.

What is the expected CAGR for the Coronary Artery Bypass Graft Market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 8.22%.

Which companies are considered key players in the Coronary Artery Bypass Graft Market?

Key players in the Coronary Artery Bypass Graft Market include Medtronic, Boston Scientific, Abbott Laboratories, and Johnson & Johnson.

What segment had the highest valuation in the Coronary Artery Bypass Graft Market in 2024?

<p>In 2024, the segment for Coronary Artery Disease had the highest valuation at 5.33 USD Billion.</p>

What is the projected valuation for the Off-Pump Coronary Artery Bypass Grafting segment by 2035?

<p>The projected valuation for the Off-Pump Coronary Artery Bypass Grafting segment is 7.0 USD Billion by 2035.</p>

How does the valuation of the Internal Mammary Artery Graft segment compare to the Saphenous Vein Graft segment in 2024?

In 2024, the Internal Mammary Artery Graft segment was valued at 4.0 USD Billion, while the Saphenous Vein Graft segment was valued at 3.99 USD Billion.

What is the projected market size for rehabilitation programs in the Coronary Artery Bypass Graft Market by 2035?

The projected market size for rehabilitation programs in the market is 5.0 USD Billion by 2035.

Which demographic factors are influencing the market?

Demographic factors influencing the market include age group, gender, comorbidities, and lifestyle factors.

What is the expected growth for the Minimally Invasive Coronary Artery Bypass Grafting segment by 2035?

The expected growth for the Minimally Invasive Coronary Artery Bypass Grafting segment is projected to reach 6.0 USD Billion by 2035.

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed cardiovascular journals, clinical publications, and authoritative cardiac health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health, European Medicines Agency (EMA) Medical Device Regulations, National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI), Centers for Disease Control and Prevention (CDC) Heart Disease Statistics, World Health Organization (WHO) Cardiovascular Disease Database, American College of Cardiology (ACC) National Cardiovascular Data Registry (NCDR), Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database, European Association for Cardio-Thoracic Surgery (EACTS) Registry Data, American Heart Association (AHA) Statistical Updates, ClinicalTrials.gov for surgical intervention studies, EU Eurostat Healthcare Statistics, OECD Health Statistics, and national cardiovascular registries from key markets including Japan's JCVSD and the UK National Adult Cardiac Surgery Audit.

These sources were employed to gather data on the prevalence of cardiovascular disease, the regulatory approval pathways for cardiac surgical devices, clinical outcomes studies, demographic risk factors, and competitive landscape analysis for on-pump systems, off-pump technologies, minimally invasive direct CABG (MIDCAB) equipment, and endoscopic vein harvesting (EVH) devices. Additionally, CABG procedure statistics were gathered.

 

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consisted of CEOs, VPs of Cardiac Surgery Business Units, regulatory affairs chiefs, R&D directors, and commercial directors from manufacturers of bypass grafts, heart-lung machines, surgical staplers, EVH systems, and cardiac surgical instruments. The demand-side sources included procurement leads from tertiary care hospitals, cardiac surgery centers, academic medical centers, and specialized cardiology clinics, as well as chief of cardiac surgery, cardiothoracic surgeons, interventional cardiologists, perfusionists, and OR administrators. Market segmentation was validated across surgical techniques (off-pump vs. on-pump), product development pipelines for anastomosis assist devices and robotic surgical systems were confirmed, and insights on hospital adoption patterns for minimally invasive techniques, bundled payment models, and surgical graft material preferences (saphenous vein vs. internal mammary artery vs. radial artery) were extracted through primary research.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

 

Market Size Estimation

Revenue mapping and volume analysis of the CABG procedure were employed to determine the global market valuation. The methodology comprised the following:

The identification of over 50 key manufacturers in North America, Europe, Asia-Pacific, and Latin America spanning cardiac surgical devices, perfusion apparatus, and graft technologies

The following is a product mapping of on-pump CABG systems, off-pump coronary artery bypass (OPCAB) devices, minimally invasive direct CABG (MIDCAB) apparatus, endoscopic vein harvesting (EVH) systems, anastomosis assist devices, and surgical graft materials (autologous and synthetic).

Examination of the annual revenues that have been reported and modeled for the cardiac surgery and coronary bypass portfolios

Manufacturers that account for 75-80% of the global CABG device market share in 2024 are included in the coverage.

Segment-specific valuations for hospitals, cardiology clinics, and research institutes are derived through extrapolation using bottom-up (procedure volume × ASP by country for single, double, triple, and quadruple bypass surgeries) and top-down (manufacturer revenue validation against STS and EACTS registry data) approaches.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓